Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1988 Oct;43(10):762–769. doi: 10.1136/thx.43.10.762

Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants.

A R Penketh 1, T W Higenbottam 1, J Hutter 1, C Coutts 1, S Stewart 1, J Wallwork 1
PMCID: PMC461502  PMID: 2849814

Abstract

The main clinical problems that follow heart-lung transplantation are opportunist infections of the lungs and pulmonary rejection. Of 23 patients undergoing heart-lung transplantation, eight had opportunist infections and 12 had at least one episode of pulmonary rejection. Cardiac rejection occurred in only one patient, who did not need treatment. Of the 12 patients who had pulmonary rejection, nine recovered fully after augmented immunosuppression with high dose corticosteroids, although one patient required additional low dose corticosteroids for eight months before making a full recovery. Fatal opportunist lung infection followed treatment for rejection in two patients. One patient developed obliterative bronchiolitis. Of the eight patients with opportunist infections, five had primary cytomegalovirus pneumonitis, acquired from the donor. All three patients treated with acyclovir died, whereas the two treated with hyperimmune globulin and dihydroxy proxymethylguanine recovered fully. Two patients developed Pneumocystis carinii pneumonia, which was treated successfully in one patient with intravenous sulphadimidine and trimethoprim. The other patient died after a further episode of rejection and aspergillus bronchitis. One patient developed a tuberculous empyema. The calculated actuarial survival at one year was 78% and at two years 67.2%. Although it is still in its innovative stage heart-lung transplantation appears to have complications and results similar to those of transplantation of other organs.

Full text

PDF
768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbara J. A., Moulsdale H., Brown S., Griffiths P. D., Berry M. J., Contreras M. Modified latex agglutination test for anticytomegalovirus, suitable for pretransfusion screening. J Clin Pathol. 1987 Jan;40(1):115–116. doi: 10.1136/jcp.40.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bowden R. A., Sayers M., Flournoy N., Newton B., Banaji M., Thomas E. D., Meyers J. D. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986 Apr 17;314(16):1006–1010. doi: 10.1056/NEJM198604173141602. [DOI] [PubMed] [Google Scholar]
  3. Brooks R. G., Hofflin J. M., Jamieson S. W., Stinson E. B., Remington J. S. Infectious complications in heart-lung transplant recipients. Am J Med. 1985 Oct;79(4):412–422. doi: 10.1016/0002-9343(85)90027-0. [DOI] [PubMed] [Google Scholar]
  4. Burke C. M., Theodore J., Baldwin J. C., Tazelaar H. D., Morris A. J., McGregor C., Shumway N. E., Robin E. D., Jamieson S. W. Twenty-eight cases of human heart-lung transplantation. Lancet. 1986 Mar 8;1(8480):517–519. doi: 10.1016/s0140-6736(86)90881-0. [DOI] [PubMed] [Google Scholar]
  5. Caves P. K., Stinson E. B., Billingham M. E., Shumway N. E. Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet. 1974 May 4;1(7862):821–826. doi: 10.1016/s0140-6736(74)90480-2. [DOI] [PubMed] [Google Scholar]
  6. Copeland J. G. Heart-lung transplantation: current status. Ann Thorac Surg. 1987 Jan;43(1):2–3. doi: 10.1016/s0003-4975(10)60153-1. [DOI] [PubMed] [Google Scholar]
  7. Dawkins K. D., Jamieson S. W., Hunt S. A., Baldwin J. C., Burke C. M., Morris A., Billingham M. E., Theodore J., Oyer P. E., Stinson E. B. Long-term results, hemodynamics, and complications after combined heart and lung transplantation. Circulation. 1985 May;71(5):919–926. doi: 10.1161/01.cir.71.5.919. [DOI] [PubMed] [Google Scholar]
  8. Dummer J. S., White L. T., Ho M., Griffith B. P., Hardesty R. L., Bahnson H. T. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis. 1985 Dec;152(6):1182–1191. doi: 10.1093/infdis/152.6.1182. [DOI] [PubMed] [Google Scholar]
  9. Griffith B. P., Hardesty R. L., Trento A., Paradis I. L., Duquesnoy R. J., Zeevi A., Dauber J. H., Dummer J. S., Thompson M. E., Gryzan S. Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg. 1987 Jan;43(1):6–16. doi: 10.1016/s0003-4975(10)60157-9. [DOI] [PubMed] [Google Scholar]
  10. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  11. Jamieson S. W., Stinson E. B., Oyer P. E., Baldwin J. C., Shumway N. E. Operative technique for heart-lung transplantation. J Thorac Cardiovasc Surg. 1984 Jun;87(6):930–935. [PubMed] [Google Scholar]
  12. Jones D. K., Hakim M., Wallwork J., Higenbottam T. W., White D. J. Serious interaction between cyclosporin A and sulphadimidine. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):728–729. doi: 10.1136/bmj.292.6522.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McGregor C. G., Baldwin J. C., Jamieson S. W., Billingham M. E., Yousem S. A., Burke C. M., Oyer P. E., Stinson E. B., Shumway N. E. Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg. 1985 Oct;90(4):623–626. [PubMed] [Google Scholar]
  14. Nunan T. O., Banatvala J. E. Cytomegalovirus infections in renal transplant recipients. Br Med J (Clin Res Ed) 1984 May 19;288(6429):1477–1478. doi: 10.1136/bmj.288.6429.1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Reitz B. A., Wallwork J. L., Hunt S. A., Pennock J. L., Billingham M. E., Oyer P. E., Stinson E. B., Shumway N. E. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982 Mar 11;306(10):557–564. doi: 10.1056/NEJM198203113061001. [DOI] [PubMed] [Google Scholar]
  16. Solis E., Kaye M. P. The Registry of the International Society for Heart Transplantation: third official report--June 1986. J Heart Transplant. 1986 Jan-Feb;5(1):2–5. [PubMed] [Google Scholar]
  17. Szmidt J., Karolak M., Sabliński T., Frunze S., Madej K., Michałowski P., Kozłowski T., Nazarewski S. Transplantation of kidneys with nonvascular anatomical abnormalities. Transplant Proc. 1988 Oct;20(5):767–767. [PubMed] [Google Scholar]
  18. Wallenburg H. C., Dekker G. A., Makovitz J. W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. doi: 10.1016/s0140-6736(86)91891-x. [DOI] [PubMed] [Google Scholar]
  19. Wreghitt T. G., Hicks J., Gray J. J., O'Connor C. Development of a competitive enzyme-linked immunosorbent assay for detecting cytomegalovirus antibody. J Med Virol. 1986 Feb;18(2):119–129. doi: 10.1002/jmv.1890180204. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES